These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17263820)

  • 1. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
    Dauendorffer JN; Rivet J; Allard A; Bachelez H
    Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
    Nakashima C; Tanioka M; Takahashi K; Miyachi Y
    Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
    Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy.
    Sanli H; Ataman S; Akay BN; Yilmaz A; Yildizlar D; Gürgey E
    J Drugs Dermatol; 2007 Aug; 6(8):834-6. PubMed ID: 17763616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
    Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
    J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
    Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
    Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
    Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.
    Jacquet A; Francois H; Frangie C; Yahiaoui Y; Ferlicot S; Micelli C; Mariette X; Durrbach A
    Nephrol Dial Transplant; 2009 Nov; 24(11):3540-2. PubMed ID: 19556300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
    Mo N; Muthu S; O'Sullivan M
    Rheumatology (Oxford); 2011 Apr; 50(4):808-10. PubMed ID: 21183450
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
    Baraliakos X; Listing J; Rudwaleit M; Brandt J; Alten R; Burmester G; Gromnica-Ihle E; Haibel H; Schewe S; Schneider M; Sörensen H; Zeidler H; Visvanathan S; Sieper J; Braun J
    J Rheumatol; 2007 Mar; 34(3):510-5. PubMed ID: 17299842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.
    Iliopoulos A; Psathakis K; Aslanidis S; Skagias L; Sfikakis PP
    Int J Tuberc Lung Dis; 2006 May; 10(5):588-90. PubMed ID: 16704045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraparesis due to exacerbation of preexisting spinal pseudoarthrosis following infliximab therapy for advanced ankylosing spondylitis.
    Sakaura H; Hosono N; Mukai Y; Fujii R; Yoshikawa H
    Spine J; 2006; 6(3):325-9. PubMed ID: 16651229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
    Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
    Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.
    Gossec L; Le Henanff A; Breban M; Vignon E; Claudepierre P; Devauchelle V; Wendling D; Lespessailles E; Euller-Ziegler L; Sibilia J; Perdriger A; Alexandre C; Dougados M
    Rheumatology (Oxford); 2006 Jul; 45(7):859-62. PubMed ID: 16436489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
    Baraliakos X; Listing J; Brandt J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Rudwaleit M; Sieper J; Braun J
    Arthritis Res Ther; 2005; 7(3):R439-44. PubMed ID: 15899030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.
    Conti F; Priori R; Chimenti MS; Coari G; Annovazzi A; Valesini G; Signore A
    Arthritis Rheum; 2005 Apr; 52(4):1224-6. PubMed ID: 15818709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
    Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
    Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.